Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Positive results from Sciele Pharma's second pivotal study of PSD502 for the treatment of PE

At the annual meeting of the Sexual Medicine Society of North America, Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC, today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).

19 Nov 2009

Political commitment to include health care coverage for smoking cessation needed

Massachusetts today announced extraordinary results from its aggressive efforts to help Medicaid beneficiaries quit smoking by providing easy access to coverage for smoking cessation medication and counseling.

19 Nov 2009

'Model' tobacco cessation program reduces smoking rate by 26%

A "model" tobacco cessation benefit offered to Massachusetts' Medicaid participants has produced an astounding 26% drop in smoking rates in only two and a half years, and has already been linked to decreases in heart attacks, hospitalizations for asthma and COPD, and a significant decrease in birth complications.

19 Nov 2009

New report finds positive association between phthalate exposure and ADHD symptoms

Phthalates are important components of many consumer products, including toys, cleaning materials, plastics, and personal care items. Studies to date on phthalates have been inconsistent, with some linking exposure to these chemicals to hormone disruptions, birth defects, asthma, and reproductive problems, while others have found no significant association between exposure and adverse effects.

19 Nov 2009

People with egg allergy can have H1N1 flu vaccine in graded doses

As flu season got underway this fall, Dr. Catherine Monteleone, an allergist, noticed that her office started to receive an unusually high number of calls from people with egg allergy. They previously had avoided flu vaccines because of their sensitivity to eggs. This year, with all the attention being paid to the novel H1N1 influenza, those patients want to be protected against flu, and they contacted her to find out if they are candidates for inoculation.

19 Nov 2009

New certification standard for cleaning products aims for reducing allergens and polluting agents

The growing asthma & allergy friendly(TM) Certification Program announced today that it has developed and adopted a certification standard and testing protocol for Non-Disinfecting Hard Surface Spray Cleaning Products. The asthma & allergy friendly(TM) Certification Program - administered by the Asthma and Allergy Foundation of America (AAFA) in partnership with the international research organization, Allergy Standards Limited (ASL) - is an independent, non-exclusive certification program created to scientifically test and identify consumer products that are more suitable for people with asthma and allergies.

18 Nov 2009

Previous flu infections can reduce the severity of H1N1

Researchers at the La Jolla Institute for Allergy & Immunology have found that previous influenza infections may provide at least some level of immunity to the H1N1 "swine" flu. "The question we asked was, "Is the swine flu more like the seasonal flu or like a totally new strain of influenza where there would be no immunity?," said Alessandro Sette, Ph.D., an internationally recognized vaccine expert and director of the La Jolla Institute's Center for Infectious Disease.

18 Nov 2009

Non-clinical data from Cytokinetics' smooth muscle contractility program presented

Cytokinetics, Incorporated announced today that three abstracts summarizing non-clinical data regarding its smooth muscle contractility program were presented at the 2009 Scientific Sessions of the American Heart Association in Orlando, Florida.

17 Nov 2009

Th22 cell to control inflammation in body to help fight off infection discovered

A new type of immune cell that can be out of control in certain chronic inflammatory diseases, worsening the symptoms of conditions like psoriasis and asthma, is described for the first time in the Journal of Clinical Investigation.

17 Nov 2009

Elsevier to publish official journal of ACAAI

Elsevier is pleased to announce that beginning with Volume 104 (2010) it will assume publication of the Annals of Allergy, Asthma & Immunology, the official journal of the American College of Allergy, Asthma & Immunology (ACAAI).

17 Nov 2009

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Sciele Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd. and Addrenex Pharmaceuticals, Inc., a privately-held U.S. pharmaceutical company specializing in developing drugs that regulate the adrenergic system, today announced that Sciele has agreed to acquire Addrenex.

16 Nov 2009

Lotus Pharmaceuticals reports $5.4 million net earnings for third-quarter 2009

Lotus Pharmaceuticals, Inc. a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical products in the People's Republic of China, today reported third-quarter 2009 net earnings were $5.4 million, or $0.11 per diluted share, compared with $3.2 million, or $0.07 per diluted share, in 2008. Net revenues were $14.5 million during the third quarter of 2009, compared with $16.7 million in the third quarter of 2008.

16 Nov 2009

Department of Health to conduct statewide clinics to administer free H1N1 vaccine

The Department of Health today announced it will conduct statewide clinics from Nov. 20-22 to administer free H1N1 vaccine to individuals in the recommended target groups that have not had previous access to the vaccine.

16 Nov 2009

University of Leicester medic presents new research findings on adult asthma

Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.

13 Nov 2009

New and effective medicines underway for treating a wide range of diseases affecting women

Women's Health Weekly recently reported that America's pharmaceutical research and biotechnology companies are working on nearly 1,000 life-changing medicines for diseases affecting women, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). The medicines are awaiting approval by the U.S. Food and Drug Administration or are in human clinical trials.

13 Nov 2009

New updated education course from PARI Respiratory Equipment

Today, PARI Respiratory Equipment launched a newly updated continuing education class, Managing Respiratory Patients Through Efficient Aerosol Delivery, rounding out their free learning program with seven classes for respiratory therapists, nurses, case managers, and pharmacists.

13 Nov 2009

Intervention to reduce over-dispensing of asthma medications effective without compromising patient safety

Research presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting shows that an intervention to reduce over-dispensing and waste of asthma medications can succeed without compromising patient safety and can result in substantial cost savings.

13 Nov 2009

American Medical Alert announces operating results for the third quarter of 2009

American Medical Alert Corp. a provider of healthcare communication services and advanced telehealth monitoring technologies, today announced operating results for the quarter and nine months ended September 30, 2009.

12 Nov 2009

Jonathan Richman to present at FDA public hearing on promoting medical devices using the Internet

Bridge Worldwide announced today that Jonathan Richman, Director of Strategic Planning, will present at the public hearing on "Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools," to be held on November 12 and 13, 2009, from 8 a.m. to 5 p.m., at the National Transportation Safety Board Conference Center in Washington, D.C. Richman is scheduled to speak on Friday, November 13, at 11:40 a.m. and 2:40 p.m. for 10 minutes per time slot. To listen to a free, live webcast of the hearing, go to: www.capitolconnection.net/capcon/fda/111209/FDAlive.htm.

12 Nov 2009

Stapled Peptides directly inhibit the Notch transcription factor complex

Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, “Direct Inhibition of the Notch Transcription Factor Complex.”

12 Nov 2009

Asthma News and Research

Further Reading

Positive results from Sciele Pharma's second pivotal study of PSD502 for the treatment of PE

Political commitment to include health care coverage for smoking cessation needed

'Model' tobacco cessation program reduces smoking rate by 26%

New report finds positive association between phthalate exposure and ADHD symptoms

People with egg allergy can have H1N1 flu vaccine in graded doses

New certification standard for cleaning products aims for reducing allergens and polluting agents

Previous flu infections can reduce the severity of H1N1

Non-clinical data from Cytokinetics' smooth muscle contractility program presented

Th22 cell to control inflammation in body to help fight off infection discovered

Elsevier to publish official journal of ACAAI

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Lotus Pharmaceuticals reports $5.4 million net earnings for third-quarter 2009

Department of Health to conduct statewide clinics to administer free H1N1 vaccine

University of Leicester medic presents new research findings on adult asthma

New and effective medicines underway for treating a wide range of diseases affecting women

New updated education course from PARI Respiratory Equipment

Intervention to reduce over-dispensing of asthma medications effective without compromising patient safety

American Medical Alert announces operating results for the third quarter of 2009

Jonathan Richman to present at FDA public hearing on promoting medical devices using the Internet

Stapled Peptides directly inhibit the Notch transcription factor complex

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News